<< Back to News

System Formulary Update
Injectable Iron Products:

Situation
The injectabel iron products class review and formulary standardization was approved by the System Pharmacy and Therapeutics Committee in September 2020.

Background
The following medications were reviewed: ferric gluconate, iron dextran, iron sucrose, ferumoxytol, ferric carboxymaltose

Assessment/Recommendation
Changes Effective: Tuesday, November 10, 2020

System P&T voted to include the following products on the UNC Health Medication Formulary: 

• Ferric gluconate
• Iron dextran
• Iron sucrose – restricted to outpatient encounters or clinic use only (ie, no inpatient use)
• Ferumoxytol – restricted to outpatient encounters or clinic use only (ie, no inpatient use)

Note: Stock of these products may vary at individual entities

As a result, the following products will be removed from the UNC Health Medication Formulary: 

• Ferric carboxymaltose